← FDA DRUG APPROVALS

FDA NDA · NDA004039

DIETHYLSTILBESTROL

Sponsor: LILLY

APPLICATION
NDA004039
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

DIETHYLSTILBESTROLDiscontinued
DIETHYLSTILBESTROL 5MG · TABLET, DELAYED RELEASE · ORAL
DIETHYLSTILBESTROLDiscontinued
DIETHYLSTILBESTROL 1MG · TABLET, DELAYED RELEASE · ORAL
DIETHYLSTILBESTROLDiscontinued
DIETHYLSTILBESTROL 0.1MG · TABLET, DELAYED RELEASE · ORAL
DIETHYLSTILBESTROLDiscontinued
DIETHYLSTILBESTROL 0.25MG · TABLET, DELAYED RELEASE · ORAL
DIETHYLSTILBESTROLDiscontinued
DIETHYLSTILBESTROL 0.5MG · TABLET, DELAYED RELEASE · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →